Reminder: The pictures displayed on this site maybe different from the actual appearance of the product,their maybe a delay in updating the recent picture if their a newly launched packaging from the manufacturer
Xospata 40 mg (Gilteritinib) Tablet
XOSPATA 40 mg (Gilteritinib) Tablet is a medicine used to treat acute myeloid leukemia (AML) with FLT3 mutations.
Trade name
Xospata 40 mg
Manufacturer
ASTELLA
Main ingreadient
GILTERITINIB
Specification
40mg*84 Tablets
Logistics
Please negotiate the logistics method with customer service, customer service Whatsapp/Wechat
Reminder
Please follow the doctor’s advice when taking medicines. The mall only guarantees the quality of the medicines and does not provide medical advice.
XOSPATA 40 mg (Gilteritinib) Tablet is a powerful antineoplastic inhibitor of the receptor tyrosine kinases (RTKs), FMS-related tyrosine kinase 3 (FLT3, STK1, or FLK2), AXL (UFO or JTK11), and anaplastic lymphoma kinase (ALK or CD246). Gilteritinib binds to and inhibits FLT3, AXL, and ALK in wild-type and mutant versions. This may disrupt the signal transduction pathways mediated by FLT3, AXL, and ALK, reducing tumor cell growth in cancer cell types that overexpress these RTKs. Gilteritinib is used to treat acute myeloid leukemia (AML) with FLT3 mutations.
FLT3, AXL, and ALK are overexpressed or mutated in various cancer cell types. They play an essential role in tumor cell proliferation and survival.
Take this medicine by mouth once a day, with or without food, as instructed by your doctor. Completely swallow the tablets. The dosage is determined by your medical condition and treatment response.